AMG 355
/ Amgen
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 12, 2024
A Study of AMG 355 Alone and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=515 | Recruiting | Sponsor: Amgen | Not yet recruiting ➔ Recruiting
Combination therapy • Enrollment open • Metastases • Monotherapy • Colorectal Cancer • Lung Cancer • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1